
Overview
Novo is a pharmaceutical wholesaler and supplier offering a wide range of services for the pharmaceutical industry and healthcare sector. The company ensures stable distribution of pharmaceutical products from manufacturers to patients, adhering to Good Distribution Practice (GDP) standards. Novo operates in six provinces, providing pharmaceutical and medical products with a commitment to maintaining stock levels and stable pricing policies.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $507,553 | |
| Profit allocation | Dividend and reserves | |
| Loans and borrowings | $0 | |
| Capital expenditure | $4,646 | |
| Foreign sales | 0.56% of revenue ($1,179,158) | |
| Revenue structure | Towary – hurt |
Filing timeliness
Financial statements were filed on time, on average 117 days early. All were audited by a statutory auditor.
- 202516/04/2026
- 202426/03/2025
- 202315/04/2024
- 202205/04/2023
- 202111/04/2022
- 202018/03/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
Joint action by two members of the management board is required to make declarations of will on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-07-30.
82 1600 1462 1739 7891 4000 0001
60 1050 1070 1000 0024 2431 0817
98 2490 0005 0000 4520 2864 1385
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $407.9K$407,861 |
Buildings and premises | $3M$3,010,031 |
Investment property | $7,860$7,860 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $515$515 | Tauron Sprzedaż sp. z o.o. | |
| Jul 29, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $20,001$20,001 | Fundusz Górnośląski S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawex sp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| Hurtap S.A. | $480,276,955.20 | hurtap.com.pl | ||
| Centrala Farmaceutyczna Cefarm S.A. | $457,052,669.59 | cefarm.com.pl | ||
| Medi&More sp. z o.o. | $275,638,188.29 | medi-more.pl | ||
| Abbvie sp. z o.o. | $226,123,797.09 | abbvie.pl | ||
| Natur Produkt Zdrovit sp. z o.o. | $205,379,396.79 | zdrovit.pl | ||
| Przedsiębiorstwo Zaopatrzenia Aptek Multi Pharme S.A. | $146,864,520.79 | multipharme.pl | ||
| Producencka Centrala Farmaceutyczna Procefar sp. z o.o. | $140,213,508.12 | procefar.pl | ||
| Tramco sp. z o.o. | $138,687,577.46 | tramco.pl | ||
| Lubfarm S.A. | $123,208,945.21 | lubfarm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-08-29 | PKD change (Removed: 46.90.Z, 64.99.Z; Added: 68.20.Z, 82.30.Z) | |
| 2023-02-15 | Address change (Mikołowska 93, 43-100, Tychy → Ul. Mikołowska 232, 43-100, Tychy) | |
| 2015-09-02 | PKD change (Removed: 7 codes) | |
| 2011-11-18 | Share capital increase (100,000.00 PLN → 1,333,000.00 PLN) | |
| 2010-07-15 | Entered in the register |
FAQ
Last updated: 2026-07-17